Tag: Sudafed pe

In a unanimous 2023 decision, an FDA advisory panel concluded that oral phenylephrine, the active ingredient in Sudafed PE, is ineffective as a nasal decongestant at its recommended dosage. This has led many to question: what does Sudafed PE actually do, and why has it been so widely available if it doesn't work?

In September 2023, a U.S. Food and Drug Administration (FDA) advisory committee unanimously concluded that oral phenylephrine is ineffective as a nasal decongestant [1.3.1, 1.3.2]. This article explores what decongestant is taken off shelves and what this means for consumers.

In September 2023, an FDA advisory panel unanimously voted that oral phenylephrine, an ingredient in products with about $1.8 billion in annual sales, is ineffective as a nasal decongestant [1.3.1, 1.2.2]. So, what cold medicine got banned or removed from shelves as a result?

In September 2023, an independent advisory committee to the U.S. Food and Drug Administration (FDA) unanimously voted that oral phenylephrine, a long-used decongestant ingredient, is ineffective. This landmark decision led to the voluntary removal of many over-the-counter (OTC) cold and allergy medications, addressing the question of: what decongestant was pulled from shelves?.

Following the Combat Methamphetamine Epidemic Act of 2005, the formulation of many oral decongestants shifted, leaving many consumers to wonder, "**What is Sudafed called now?**". The original, more effective pseudoephedrine is still available, but it has been largely replaced on store shelves with the less potent active ingredient, phenylephrine.